 |
       |
|
|
|||||||||||||||||||||||
 |
||||||||||||||||||||||||
r. Chen is a co-founder of KAI Pharmaceuticals, a Skyline portfolio company, where he served in a number of positions, including Senior Director of Technology. He received a BA in Biochemistry from University of California at Berkeley in and a Ph.D. from the Department of Molecular Pharmacology at Stanford University. He received an MBA from Stanford Business School in 2009. 
Home About UsOur TeamOur PortfolioWhat We Look ForContact Us2010 Copyright © Skyline Management LLC
|
|
|
|
|
|||||||||||||||||||||||
|
||||||||||||||||||||||||
| HomeAbout UsOur TeamOur PortfolioWhat We Look ForContact Us 2010 Copyright © Skyline Management LLC
|
